Dan Spiegelman
Director/Board Member bei KYVERNA THERAPEUTICS, INC.
Vermögen: 863 311 $ am 31.03.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Christopher Henney | M | 83 |
Xcyte Therapies, Inc.
| 19 Jahre |
| Richard D. van Doren | M | 47 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | 8 Jahre |
| Louis Lange | M | 72 |
Recardia Therapeutics, Inc.
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 20 Jahre |
| Charles Homcy | M | 75 |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | - |
| Dominic Borie | M | 61 | 4 Jahre | |
| Michael Grey | M | 71 | 7 Jahre | |
| Fred Cohen | M | 67 |
Stanford University
| 11 Jahre |
| Srini Akkaraju Akkaraju | M | 56 |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | 8 Jahre |
| S. Phanstiel | F | 65 | 15 Jahre | |
| Camilla Simpson | F | 52 | 10 Jahre | |
| Jason V. Coloma | M | - |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | - |
| Paul Diaz | M | 61 | 4 Jahre | |
| Perry Karsen | M | 69 |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | 4 Jahre |
| Cory Freedland | M | 48 |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | 7 Jahre |
| Judith Robertson | F | 64 | 3 Jahre | |
| Christine O'Brien | F | - |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | 9 Jahre |
| Karen Adams | F | - | 3 Jahre | |
| Julia Haller | M | 69 | 3 Jahre | |
| Elizabeth Anderson | F | 66 | 5 Jahre | |
| Willard Dere | M | 70 | 8 Jahre | |
| Brian Kotzin | M | 74 | 5 Jahre | |
| David Pyott | M | 70 | 8 Jahre | |
| Ryan Jones | M | 36 | 6 Jahre | |
| Betsy Santos | F | - |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California.
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 5 Jahre |
| Sekar Kathiresan | M | 52 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 2 Jahre |
| Rashmi Kumar | F | 53 | 4 Jahre | |
| Kevin Haas | M | 38 | 6 Jahre | |
| Thomas P. Slavin | M | - | 4 Jahre | |
| Glenn Farrell | M | - | 2 Jahre | |
| Javier Szwarcberg | M | 54 | 2 Jahre | |
| Dale Muzzey | M | 44 | 10 Jahre | |
| Sushma Gambhir | F | - |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | 4 Jahre |
| Bali Muralidhar | M | 44 | 4 Jahre | |
| Samir Gharib | M | 41 | 4 Jahre | |
| Dennis Joseph Slamon | M | 75 | 10 Jahre | |
| Robert Hombach | M | 58 | 7 Jahre | |
| Ian Clark | M | 62 | 3 Jahre | |
| Lee Newcomer | M | 71 | 5 Jahre | |
| Colleen Reitan | F | 64 | 5 Jahre | |
| Heiner Dreismann | M | 69 | 14 Jahre | |
| Tiba Aynechi | M | 48 | 8 Jahre | |
| Peter Maag | M | 56 | 2 Jahre | |
| Daniel Skovronsky | M | 50 | 4 Jahre | |
| Steve Liapis | M | 36 | 2 Jahre | |
| Steve Kelsey | M | 63 | 4 Jahre | |
| Kirk Ways | M | 72 | 3 Jahre | |
| J. Whitaker | M | 68 | 14 Jahre | |
| Niall O'Donnell | M | 51 | 8 Jahre | |
| Percival Barretto-Ko | M | 51 | 1 Jahre | |
| Beth Seidenberg | M | 67 | 6 Jahre | |
| Catherine Sohn | M | 71 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | 3 Jahre |
| Donald R. Stanski | M | 74 |
Stanford University
| 45 Jahre |
| John Oberg | M | - | 1 Jahre | |
| Bruno Gagnon | M | - | 2 Jahre | |
| Timothy M. Duffy | M | 63 | 14 Jahre | |
| Jeffrey Pfeffer | M | 77 |
Stanford University
| 45 Jahre |
| James Plummer | M | 79 |
Stanford University
| 46 Jahre |
| Jeremy Levin | M | 70 | 4 Jahre | |
| Quinton Oswald | M | - | 2 Jahre | |
| Susan Orr | M | - | 2 Jahre | |
| Roger Kornberg | M | 77 |
Stanford University
| 46 Jahre |
| Frédéric Guerard | M | 51 | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert L. Kirkman | M | 75 |
Xcyte Therapies, Inc.
| 12 Jahre |
| R. Riggsbee | M | 53 | 10 Jahre | |
| John Orwin | M | 62 | 4 Jahre | |
| Pierre LaPalme | M | 83 | 12 Jahre | |
| Arlene Morris | F | 72 | 8 Jahre | |
| Nancy Whiting | M | 51 | - | |
| Patrick Treanor | M | - | - | |
| Charlotte Arnold | F | - | - | |
| Scott Myers | M | 57 | 2 Jahre | |
| Kenneth Hillan | M | 63 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 20 Jahre |
| Mark Wood | M | 57 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 15 Jahre |
| Edward A. Taylor | M | 81 | 13 Jahre | |
| Adora Ndu | M | 43 | 5 Jahre | |
| John Henderson | M | 79 | 16 Jahre | |
| Ted Love | M | 65 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 12 Jahre |
| William Young | M | 79 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 8 Jahre |
| Walter A. Gilbert | M | 92 | 29 Jahre | |
| Stephen Wurzburg | M | - |
Stanford University
| 8 Jahre |
| Hollings Renton | M | 77 | 5 Jahre | |
| G. Kirk Raab | M | 88 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 10 Jahre |
| Peter St. Geme | M | - |
Stanford University
| 5 Jahre |
| Kyt-Tack Hong | M | 71 |
Stanford University
| 5 Jahre |
| Ron Hunt | M | 59 | 2 Jahre | |
| John Butler | M | 59 | 3 Jahre | |
| James Healy | M | 58 | 8 Jahre | |
| Scott Rocklage | M | 69 | 7 Jahre | |
| Abdullah Atalar | M | 70 |
Stanford University
| 3 Jahre |
| Mark Williams | M | 70 |
Stanford University
| 4 Jahre |
| Herbert Cross | M | 52 | 3 Jahre | |
| Rachel Leheny | M | 60 | 3 Jahre | |
| Philip T. Sager | M | 68 | 5 Jahre | |
| Tricia Borga Suvari | F | 63 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 11 Jahre |
| Thomas Schuetz | M | 63 | 6 Jahre | |
| Chuck Hadley | M | - |
Stanford University
| 5 Jahre |
| Keith Leonard | M | 62 | 6 Jahre | |
| Claire J. Lockey | F | 71 | 5 Jahre | |
| Ali Mahdavi | M | 71 | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 91 | 91,92% |
| Australien | 8 | 8,08% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Dan Spiegelman
- Persönliches Netzwerk
